Position in TLRY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$2,141
New position
Shares Held
331
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SALEM INVESTMENT COUNSELORS INC holds $527,346 across 13 Drug Manufacturers - Specialty & Generic names. TLRY ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
16,696 | $225,562 | |
| 2 | HLN |
Haleon plc
|
9,114 | $91,231 | |
| 3 | ZTS |
Zoetis Inc.
|
586 | $69,271 | |
| 4 | DERM |
Journey Medical Corp
|
14,300 | $67,067 | |
| 5 | HROW |
Harrow, Inc.
|
1,300 | $45,838 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
1,025 | $21,279 | |
| 7 | TLRY |
Tilray Brands, Inc.
This page
|
331 | $2,141 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
200 | $1,904 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,141 | 331 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||